SFI
IMUX icon

Susquehanna Fundamental Investments’s Immunic IMUX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,767
Closed -$56K – 1336
2022
Q3 		$56K Buy
+1,767
New +$74K ﹤0.01% 1370
2021
Q2 		– Sell
-2,951
Closed -$470K – 1708
2021
Q1 		$470K Buy
2,951
+361
+14% +$61.2K 0.01% 1160
2020
Q4 		$396K Sell
2,590
-680
-21% -$122K 0.01% 1179
2020
Q3 		$607K Buy
3,270
+1,760
+117% +$288K 0.02% 815
2020
Q2 		$183K Buy
+1,510
New +$154K 0.01% 846

Other funds holding IMUX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Susquehanna Fundamental Investments's IMUX Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of Immunic (IMUX) in Q4 2022, closing a stake of 1,767 shares — an estimated $56K sold.

Susquehanna Fundamental Investments first reported a position in IMUX in Q2 2020 and held it in 5 quarters. The position peaked at $607K in Q3 2020. 58 funds tracked by Wall St. Rank hold IMUX as of Q4 2022.

  • Susquehanna Fundamental Investments reported no remaining Immunic position as of Q4 2022 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 1,767 Immunic shares in Q4 2022, an estimated $56K.
  • Susquehanna Fundamental Investments first reported a position in Immunic in Q2 2020 and held it in 5 quarters.
  • Susquehanna Fundamental Investments's Immunic position peaked at $607K in Q3 2020.
  • 58 funds tracked by Wall St. Rank held Immunic as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.